Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study

Monnet, E; Choy, EH; McInnes, I; Kobakhidze, T; de Graaf, K; Jacqmin, P; Lapeyre, G; de Min, C

Monnet, E (corresponding author), NovImmune SA, Clin Dev, CH-1228 Geneva, Plan Les Ouates, Switzerland.

ANNALS OF THE RHEUMATIC DISEASES, 2020; 79 (3): 316

Abstract

Objectives Anti-citrullinated protein antibodies (ACPAs) form immune complexes with citrullinated proteins binding toll-like receptor (TLR) 4, which h......

Full Text Link